SEN15 Inhibitors
SEN15 inhibitors consist of a group of chemical compounds that indirectly suppress the functional activity of SEN15 by influencing various signaling pathways critical for cell growth, proliferation, and stress response, which are processes that may require SEN15's role in tRNA splicing. For instance, Rapamycin and WYE-354, both mTOR inhibitors, lead to the deactivation of downstream signals involved in protein synthesis. This reduction in protein synthesis demand is likely to result in a decreased need for the mature tRNA that SEN15 helps to splice, thus indirectly diminishing its function. Similarly, LY 294002 and ZSTK474, by targeting PI3K, suppress AKT activation and the subsequent PI3K/AKT/mTOR pathway, leading to a downregulation of processes that would otherwise necessitate SEN15's tRNA splicing activity.
Furthermore, a decrease in cell proliferation due to MEK inhibitors like PD98059 and U0126 indirectly lessens the requirement for SEN15's function. Inhibitors such as SB 203580, Triciribine, and PF 4708671 disrupt various components of intrcellular signaling cascades, such as p38 MAPK, AKT, and p70 S6 kinase, each contributing to a reduced cellular demand for protein synthesis, and thus, diminished reliance on SEN15's role in tRNA splicing. The inhibition of these pathways suggests a correlated decrease in the functional necessity for SEN15, as the cell's reduced requirement for protein synthesis indirectly leads to less need for the tRNA processing that SEN15 facilitates. Additionally, compounds like Torin 2, AZD2014, and BEZ235 exert their effects by robustly suppressing mTOR signaling and the PI3K/mTOR axis, respectively. This comprehensive pathway inhibition further supports the anticipation of reduced SEN15 activity due to a broader decrease in cellular growth and proliferation signals, thereby providing a multi-faceted approach to the indirect inhibition of SEN15's involvement in tRNA splicing.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that leads to the deactivation of downstream signals required for cell growth and proliferation. Since SEN15 is involved in the splicing of tRNA and the mTOR pathway can affect the synthesis and maturation of ribosomal components, inhibition of this pathway would likely lead to reduced availability of mature tRNA, indirectly diminishing the functional necessity of SEN15. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that prevents the phosphorylation and activation of AKT, leading to the suppression of the PI3K/AKT/mTOR pathway. By dampening this pathway, the cellular processes that require SEN15's role in tRNA splicing may be downregulated, thus indirectly reducing the functional activity of SEN15. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that disrupts the p38 MAPK signaling pathway, which is involved in stress response and cell differentiation. SEN15 function could be indirectly reduced as cellular demand for protein synthesis and accordingly tRNA splicing may decrease under diminished stress response signaling. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An AKT inhibitor that prevents AKT activation and downstream signaling. This compound would lead to a reduced cellular demand for protein synthesis by limiting growth signaling, thereby potentially decreasing the functional need for SEN15's tRNA splicing activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that prevents the activation of ERK, which may lead to reduced cell proliferation. With lower proliferation rates, the requirement for tRNA splicing, and thus SEN15, could be indirectly diminished. | ||||||
WYE-354 | 1062169-56-5 | sc-364652 sc-364652A | 10 mg 50 mg | $286.00 $1200.00 | ||
An mTOR inhibitor that suppresses mTOR signaling, potentially leading to diminished tRNA splicing activity as the demand for protein synthesis decreases, thereby indirectly affecting the functional activity of SEN15. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that impairs ERK signaling and could, by reducing cellular proliferation, indirectly decrease the functional demand for SEN15 activity in tRNA splicing. | ||||||
ZSTK 474 | 475110-96-4 | sc-475495 | 5 mg | $75.00 | ||
A PI3K inhibitor that, by inhibiting PI3K/AKT signaling, could indirectly lead to reduced requirements for SEN15 activity due to diminished translation and proliferation signals. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $179.00 $700.00 | 9 | |
A p70 S6 kinase inhibitor that, by inhibiting downstream mTOR signaling, could lead to reduced protein synthesis demand and thereby indirectly reduce the functional activity of SEN15. | ||||||
AZD2014 | 1009298-59-2 | sc-364420 | 5 mg | $303.00 | 2 | |
An mTOR kinase inhibitor that robustly suppresses mTORC1 and mTORC2 signaling, potentially lowering the requirement for SEN15 activity due to a decrease in protein synthesis and cell growth. | ||||||